Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis

Open access

Abstract

BACKGROUND: The tolerability of oral iron supplementation for the treatment of iron deficiency anemia is disputed. OBJECTIVE: Our aim was to quantify the odds of GI side-effects in adults related to current gold standard oral iron therapy, namely ferrous sulfate. METHODS: Systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating GI side-effects that included ferrous sulfate and a comparator that was either placebo or intravenous (i.v.) iron. Random effects meta-analysis modelling was undertaken and study heterogeneity was summarised using I2 statistics. RESULTS: Forty three trials comprising 6831 adult participants were included. Twenty trials (n = 3168) had a placebo arm and twenty three trials (n = 3663) had an active comparator arm of i.v. iron. Ferrous sulfate supplementation significantly increased risk of GI side-effects versus placebo with an odds ratio (OR) of 2.32 [95% CI 1.74-3.08, p<0.0001, I2 = 53.6%] and versus i.v. iron with an OR of 3.05 [95% CI 2.07-4.48, p<0.0001, I2 = 41.6%]. Subgroup analysis in IBD patients showed a similar effect versus i.v. iron (OR = 3.14, 95% CI 1.34-7.36, p = 0.008, I2 = 0%). Likewise, subgroup analysis of pooled data from 7 RCTs in pregnant women (n = 1028) showed a statistically significant increased risk of GI side-effects for ferrous sulfate although there was marked heterogeneity in the data (OR = 3.33, 95% CI 1.19-9.28, p = 0.02, I2 = 66.1%). Meta-regression did not provide significant evidence of an association between the study OR and the iron dose. CONCLUSIONS: Our meta-analysis confirms that ferrous sulfate is associated with a significant increase in gastrointestinal-specific side-effects but does not find a relationship with dose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0117383

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Study flow diagram. RCT, randomized controlled trial; ICU, intensive care unit. (1) This study was carried out by the co-authors and is currently submitted for publication and under review. A list compiling the 88 references that were not obtained is provided in Table A in S1 File.
Fig 1 Study flow diagram. RCT, randomized controlled trial; ICU, intensive care unit. (1) This study was carried out by the co-authors and is currently submitted for publication and under review. A list compiling the 88 references that were not obtained is provided in Table A in S1 File.CC BY · PubMed Central
Fig 2 Forest plot for the effect of daily ferrous sulfate supplementation on the incidence of gastrointestinal side-effects in placebo-controlled RCTs. Data for random-effects meta-analysis are shown. For each study the closed diamond represents the mean estimated effect and the horizontal lines the 95% CI. The grey shaded area surrounding each closed diamond represents the weight of each study in the analysis. Weight was assigned based on the (inverse of) the sum of the within-study variance and between study variance. Open diamonds represent the subgroup mean difference and pooled overall mean differences as shown. Test for overall effect: z-score = 7.54 (other), 0.20 (pregnant), 5.79 (overall); p-value <0.0001 (other), = 0.8 (pregnant), <0.0001 (overall). OR, odds ratio; CI, confidence interval. Data shown for 20 RCTs (n = 3168).
Fig 2 Forest plot for the effect of daily ferrous sulfate supplementation on the incidence of gastrointestinal side-effects in placebo-controlled RCTs. Data for random-effects meta-analysis are shown. For each study the closed diamond represents the mean estimated effect and the horizontal lines the 95% CI. The grey shaded area surrounding each closed diamond represents the weight of each study in the analysis. Weight was assigned based on the (inverse of) the sum of the within-study variance and between study variance. Open diamonds represent the subgroup mean difference and pooled overall mean differences as shown. Test for overall effect: z-score = 7.54 (other), 0.20 (pregnant), 5.79 (overall); p-value <0.0001 (other), = 0.8 (pregnant), <0.0001 (overall). OR, odds ratio; CI, confidence interval. Data shown for 20 RCTs (n = 3168).CC BY · PubMed Central
Fig 3 Effect of daily ferrous sulfate supplementation on the incidence of gastrointestinal side-effects and hemoglobin repletion in intravenous iron-controlled RCTs. A, Forest plot for random-effects meta-analysis of the effect of ferrous sulfate supplementation on the incidence of gastrointestinal side-effects against intravenous iron. For each study the closed diamond represents the mean estimated effect and the horizontal lines the 95% CI. The grey shaded area surrounding each closed diamond represents the weight of each study in the analysis. Weight was assigned based on (inverse of) the sum of the within-study variance and between study variance. Open diamonds represent the subgroup mean difference and pooled overall mean differences as shown. Test for overall effect: z-score = 4.36 (other), 3.05 (pregnant), 2.63 (IBD), 5.67(overall); p-value <0.0001 (other), = 0.002 (pregnant), = 0.008 (IBD), <0.0001 (overall). OR, odds ratio; CI, confidence interval. B, Hemoglobin increase in both ferrous sulfate (FeSO4) and intravenous iron (IV iron) arms from baseline (open circles) to end of study intervention (closed circles). Data shown for 20 RCTs (n = 3261).
Fig 3 Effect of daily ferrous sulfate supplementation on the incidence of gastrointestinal side-effects and hemoglobin repletion in intravenous iron-controlled RCTs. A, Forest plot for random-effects meta-analysis of the effect of ferrous sulfate supplementation on the incidence of gastrointestinal side-effects against intravenous iron. For each study the closed diamond represents the mean estimated effect and the horizontal lines the 95% CI. The grey shaded area surrounding each closed diamond represents the weight of each study in the analysis. Weight was assigned based on (inverse of) the sum of the within-study variance and between study variance. Open diamonds represent the subgroup mean difference and pooled overall mean differences as shown. Test for overall effect: z-score = 4.36 (other), 3.05 (pregnant), 2.63 (IBD), 5.67(overall); p-value <0.0001 (other), = 0.002 (pregnant), = 0.008 (IBD), <0.0001 (overall). OR, odds ratio; CI, confidence interval. B, Hemoglobin increase in both ferrous sulfate (FeSO4) and intravenous iron (IV iron) arms from baseline (open circles) to end of study intervention (closed circles). Data shown for 20 RCTs (n = 3261).CC BY · PubMed Central
Fig 4 Forest plot for the effect of daily ferrous sulfate supplementation on the incidence of gastrointestinal side-effects in pregnant women. Data for random-effects subgroup meta-analysis are shown (7RCTs, n = 1028). For each study the closed diamond represents the mean estimated effect and the horizontal lines the 95% CI. The grey shaded area surrounding each closed diamond represents the weight of each study in the analysis. Weight was assigned based on (inverse of) the sum of the within-study variance and between study variance. Open diamonds represent the subgroup mean difference and pooled overall mean differences as shown. Test for overall effect: z-score = 2.29; p = 0.02. OR, odds ratio; CI, confidence interval.
Fig 4 Forest plot for the effect of daily ferrous sulfate supplementation on the incidence of gastrointestinal side-effects in pregnant women. Data for random-effects subgroup meta-analysis are shown (7RCTs, n = 1028). For each study the closed diamond represents the mean estimated effect and the horizontal lines the 95% CI. The grey shaded area surrounding each closed diamond represents the weight of each study in the analysis. Weight was assigned based on (inverse of) the sum of the within-study variance and between study variance. Open diamonds represent the subgroup mean difference and pooled overall mean differences as shown. Test for overall effect: z-score = 2.29; p = 0.02. OR, odds ratio; CI, confidence interval.CC BY · PubMed Central
Fig 5 Meta-regression analysis of the association between daily iron dose and the odds ratio of gastrointestinal side-effects. A, data from 20 placebo-controlled RCTs (n = 3168); B, data from 23 IV iron-controlled RCTs (n = 3663). Individual studies are represented by circles, with the size of the circle being inversely proportional to the variance of the estimated effect (i.e the larger the circle, the more precise the estimated effect). The dotted lines represent the regression line for the analysis. Closed circles, studies with modified release ferrous sulfate; open circles, studies with conventional ferrous sulfate (i.e. not modified-release). All studies used daily posology.
Fig 5 Meta-regression analysis of the association between daily iron dose and the odds ratio of gastrointestinal side-effects. A, data from 20 placebo-controlled RCTs (n = 3168); B, data from 23 IV iron-controlled RCTs (n = 3663). Individual studies are represented by circles, with the size of the circle being inversely proportional to the variance of the estimated effect (i.e the larger the circle, the more precise the estimated effect). The dotted lines represent the regression line for the analysis. Closed circles, studies with modified release ferrous sulfate; open circles, studies with conventional ferrous sulfate (i.e. not modified-release). All studies used daily posology.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Research works printed but not linked: 6

  1. L Hallberg, 1966, Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form, Acta medica Scandinavica Supplementum, 180, 3, 10.1111/j.0954-6820.1966.tb19403.x · DOI
  2. R Langstaff, 1993, Treatment of iron-deficiency anaemia: A lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate, Br J Clin Res, 4, 191
  3. S Lindgren, 2009, Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study, Scand J Gastroenterol, 44, 838, 10.1080/00365520902839667 · DOI · Paper page
  4. C Gasche, 2011, Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party, Z Gastroenterol, 49, 627
  5. L Saha, 2007, Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women, MedGenMed: Medscape general medicine, 9, 1
  6. Pacheco J Vazquez, 1980, A comparative study of i.v. iron dextran and an oral combination of ferrous sulfate, cyanocobalamin and folic acid in obstetrical patients, Investigacion Medica International, 7, 129

Cited by

See all 893

Metadata

Authors
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J.
Affiliations
  • MRC Elsie Widdowson Laboratory (GB)
  • MRC Biostatistics Unit (GB)
Corresponding author
Pereira, Dora I. A.
Venue
PLOS ONE
Published
2015-02-20
Volume
10
Issue
2
Pages
e0117383
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2049123117
Cited by
833
References
86
Citations by year
2026: 117 · 2025: 90 · 2024: 91 · 2023: 101 · 2022: 98 · 2021: 75 · 2020: 80 · 2019: 58 · 2018: 44 · 2017: 41 · 2016: 26 · 2015: 11
FWCI
6.08
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • UNICEF
  • Medical Research Council (U105960399, G0800860)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
ferrous sulfate, oral iron supplementation, gastrointestinal adverse effects, iron deficiency anemia, intravenous iron, tolerability, inflammatory bowel disease, pregnancy, iron dosage
MeSH terms
Clinical Trials as Topic, Ferrous Compounds, Gastrointestinal Diseases, Humans, Placebo Effect, Odds Ratio, Databases, Factual, Anemia, Iron-Deficiency, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0117383
The paper
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015). Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0117383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.